Our findings indicated that the up‐regulation of NDRG1 by HIF‐1/2α may counteract the cancer‐promoting effect of HIF‐1/2α in VHL‐deficient ccRCC. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.